Can your PACE program answer the only V28 question that matters?
"Exactly how many dollars are at risk, and which diagnoses are responsible?" Most PACE leaders know something is changing under V28. Very few can translate that change into a specific dollar exposure tied to specific diagnoses. Every downstream decision, staffing, documentation strategy, vendor spend, is being made without that clarity.
What's Inside
- ✅ Translate V28 from a policy update into a dollar-level exposure report, not percentages, not abstractions, actual revenue at risk by diagnosis
- ✅ Shift from volume-based coding to prevalence-driven gap identification, with a framework for aligning Population Health, Medical Leadership, and Operations
- ✅ Redesign workflows around the high-value diagnoses that now carry strategic importance under V28, with clear role ownership at each step
- ✅ Treat documentation risk as a revenue protection function, with continuous oversight, not episodic sampling
- ✅ Use automation to absorb what human teams physically cannot scale, and retrain clinicians on what still matters, continuously